Stanojevic says one of the key findings of the drug’s impact was that the estimated age of survival for an individual with CF would improve by 9.2 years over the course of 10 years. Death rates would reduce by 15 per cent, she says.
Stanojevic says this therapy could potentially be effective for 90 per cent of people living with cystic fibrosis in Canada.
”It’s thousands of people in Canada where their disease could be completely changed,” she said.
Saunders was given a copy of the study’s findings last week and he says he was in shock.
“Just reading that one-pager brought me to tears. It was probably one of the most mind-bending experiences of my adult life, to see how much of an impact this one little pill can have on so many people,” Saunders says.